Cary Claiborne is the Chief Executive Officer of Adial Pharmaceuticals, a clinical-stage biopharmaceutical company focused on treatments for alcohol use.
Cary Claiborne is the Chief Executive Officer of Adial Pharmaceuticals, a clinical-stage biopharmaceutical company focused on treatments for alcohol use disorder and other addictions. He has discussed the company's lead investigational program, AD04, and its development path toward later-stage clinical testing.
Full founder directory · Investor directory · Company funding database · Fundraising library